InfuSystem reaffirms 6%-8% revenue growth and 20%+ EBITDA margin outlook as profitability strategy advances
Source: SeekingAlpha
2025-11-04 12:57:17 ET
More on InfuSystem
- InfuSystem Holdings, Inc. (INFU) Q3 2025 Earnings Call Transcript
- InfuSystem: A New Sheriff In Town
- InfuSystem reports mixed Q3 results; reaffirms FY25 outlook
- InfuSystem Q3 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on InfuSystem
Read the full article on Seeking Alpha
For further details see:
InfuSystem reaffirms 6%–8% revenue growth and 20%+ EBITDA margin outlook as profitability strategy advances
InfuSystems Holdings Inc.
NASDAQ: INFU
INFU Trading
2.71% G/L:
$9.86 Last:
48,004 Volume:
$9.69 Open:
INFU Latest News
February 24, 2026 06:30:00 am
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
February 17, 2026 06:30:00 am
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
December 10, 2025 05:37:00 pm
Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026
November 10, 2025 04:30:00 pm
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
INFU Stock Data
$154,046,586
18,017,858
0.09%
30
N/A
Medical Equipment & Supplies
Healthcare
US
Rochester Hills
